Nikolaj Dich Sølvsten

Nikolaj Dich Sølvsten is a Physician Scientist affiliated with Aalborg University under the The Faculty of Medicine and the Department of Gastrointestinal Surgery. His research focuses on innovative cancer treatments, particularly combining immunotherapy and electroporation techniques for pancreatic cancer and liver metastases.

Research Trends: Recent publications highlight his work on Pembrolizumab (an immune checkpoint inhibitor) and Irreversible Electroporation as a dual modality for targeting liver metastases in pancreatic cancer patients. This aligns with his expertise in gastrointestinal oncology and translational medicine.

Publications: He has contributed to two key works in 2023 and 2024, focusing on clinical applications of immunotherapy and electroporation. These studies are part of a broader effort to enhance anti-cancer immunity and ablation techniques.